BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 21362138)

  • 1. Hyaluronan-CD44 interactions as potential targets for cancer therapy.
    Misra S; Heldin P; Hascall VC; Karamanos NK; Skandalis SS; Markwald RR; Ghatak S
    FEBS J; 2011 May; 278(9):1429-43. PubMed ID: 21362138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44: structure, function, and association with the malignant process.
    Naor D; Sionov RV; Ish-Shalom D
    Adv Cancer Res; 1997; 71():241-319. PubMed ID: 9111868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal hyaluronan interaction with epithelial CD44 variants promotes prostate cancer invasiveness by augmenting expression and function of hepatocyte growth factor and androgen receptor.
    Ghatak S; Hascall VC; Markwald RR; Misra S
    J Biol Chem; 2010 Jun; 285(26):19821-32. PubMed ID: 20200161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PDGF suppresses the sulfation of CD44v and potentiates CD44v-mediated binding of colon carcinoma cells to fibrin under flow.
    Alves CS; Konstantopoulos K
    PLoS One; 2012; 7(10):e41472. PubMed ID: 23056168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer.
    Karousou E; Misra S; Ghatak S; Dobra K; Götte M; Vigetti D; Passi A; Karamanos NK; Skandalis SS
    Matrix Biol; 2017 May; 59():3-22. PubMed ID: 27746219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44s Assembles Hyaluronan Coat on Filopodia and Extracellular Vesicles and Induces Tumorigenicity of MKN74 Gastric Carcinoma Cells.
    Härkönen K; Oikari S; Kyykallio H; Capra J; Hakkola S; Ketola K; Thanigai Arasu U; Daaboul G; Malloy A; Oliveira C; Jokelainen O; Sironen R; Hartikainen JM; Rilla K
    Cells; 2019 Mar; 8(3):. PubMed ID: 30909497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct kinetic and molecular requirements govern CD44 binding to hyaluronan versus fibrin(ogen).
    Raman PS; Alves CS; Wirtz D; Konstantopoulos K
    Biophys J; 2012 Aug; 103(3):415-423. PubMed ID: 22947857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoform switch of CD44 induces different chemotactic and tumorigenic ability in gallbladder cancer.
    Miwa T; Nagata T; Kojima H; Sekine S; Okumura T
    Int J Oncol; 2017 Sep; 51(3):771-780. PubMed ID: 28677740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44-dependent lymphoma cell dissemination: a cell surface CD44 variant, rather than standard CD44, supports in vitro lymphoma cell rolling on hyaluronic acid substrate and its in vivo accumulation in the peripheral lymph nodes.
    Wallach-Dayan SB; Grabovsky V; Moll J; Sleeman J; Herrlich P; Alon R; Naor D
    J Cell Sci; 2001 Oct; 114(Pt 19):3463-77. PubMed ID: 11682606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion.
    Afify A; Purnell P; Nguyen L
    Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity.
    Sleeman J; Rudy W; Hofmann M; Moll J; Herrlich P; Ponta H
    J Cell Biol; 1996 Nov; 135(4):1139-50. PubMed ID: 8922392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronan-CD44 interaction promotes microRNA signaling and RhoGTPase activation leading to tumor progression.
    Bourguignon LY
    Small GTPases; 2012; 3(1):53-9. PubMed ID: 22714418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44 isoform-cytoskeleton interaction in oncogenic signaling and tumor progression.
    Bourguignon LY; Zhu D; Zhu H
    Front Biosci; 1998 Jul; 3():d637-49. PubMed ID: 9634539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A CD44v
    Hu J; Li G; Zhang P; Zhuang X; Hu G
    Cell Death Dis; 2017 Mar; 8(3):e2679. PubMed ID: 28300837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of hyaluronan and CD44 in cancer and viral infections.
    Heldin P; Kolliopoulos C; Lin CY; Heldin CH
    Cell Signal; 2020 Jan; 65():109427. PubMed ID: 31654718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients.
    Li Z; Chen K; Jiang P; Zhang X; Li X; Li Z
    Diagn Pathol; 2014 Apr; 9():79. PubMed ID: 24708709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions.
    Shirure VS; Liu T; Delgadillo LF; Cuckler CM; Tees DF; Benencia F; Goetz DJ; Burdick MM
    Am J Physiol Cell Physiol; 2015 Jan; 308(1):C68-78. PubMed ID: 25339657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44 and hyaluronan binding by human myeloid cells.
    Smadja-Joffe F; Legras S; Girard N; Li Y; Delpech B; Bloget F; Morimoto K; Le Bousse-Kerdiles C; Clay D; Jasmin C; Levesque JP
    Leuk Lymphoma; 1996 May; 21(5-6):407-20, color plates following 528. PubMed ID: 9172805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of CD44 shRNA/nanoparticles within cancer cells: perturbation of hyaluronan/CD44v6 interactions and reduction in adenoma growth in Apc Min/+ MICE.
    Misra S; Hascall VC; De Giovanni C; Markwald RR; Ghatak S
    J Biol Chem; 2009 May; 284(18):12432-46. PubMed ID: 19246453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.